Singh Arun D, Topham Allan
Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Ophthalmology. 2003 May;110(5):956-61. doi: 10.1016/S0161-6420(03)00078-2.
To determine the incidence of primary uveal melanoma in the United States over a 25-year period from 1973 to 1997.
Systematic review of existing databases.
Two thousand four hundred ninety-three patients with primary uveal melanoma (International Classification of Oncology [ICDO-2] codes C69.3 [choroid melanoma] and C69.4 [ciliary body and iris]) derived from the Surveillance, Epidemiology, and End Results (SEER) program database in the United States from 1973 to 1997.
The significance of trend in age-adjusted incidence rate was determined using chi-square test, and 95% confidence intervals were calculated.
The age-adjusted incidence rate.
There was a total of 2493 cases of uveal melanoma, representing 2.9% of all recorded cases of melanoma. Almost all cases (99.4%) were reported by the hospitals, and histopathologic confirmation was available in 81.3% of cases. The mean age-adjusted incidence of uveal melanoma in the United States was 4.3 per million (4.1-4.5; 95% confidence interval [CI]). Most cases (97.8%) occurred in the white population. There was significant variation of incidence between genders (males, 4.9 [4.6-5.2] 95% CI interval; females, 3.7 [3.5-3.9] 95% CI interval). There was no significant variation of incidence by the geographic location of the registry and over the entire period of observation (chi-square test).
The mean age-adjusted incidence of uveal melanoma (4.3 per million) in the United States is similar to that reported from European countries. The age-adjusted incidence rate of uveal melanoma has remained stable for the past 25 years.
确定1973年至1997年这25年间美国原发性葡萄膜黑色素瘤的发病率。
对现有数据库进行系统评价。
从美国监测、流行病学和最终结果(SEER)项目数据库中选取的2493例原发性葡萄膜黑色素瘤患者(国际肿瘤学分类[ICDO-2]编码C69.3[脉络膜黑色素瘤]和C69.4[睫状体和虹膜]),时间跨度为1973年至1997年。
采用卡方检验确定年龄调整发病率趋势的显著性,并计算95%置信区间。
年龄调整发病率。
共有2493例葡萄膜黑色素瘤病例,占所有记录黑色素瘤病例的2.9%。几乎所有病例(99.4%)由医院报告,81.3%的病例有组织病理学确诊。美国葡萄膜黑色素瘤的平均年龄调整发病率为每百万4.3例(4.1 - 4.5;95%置信区间[CI])。大多数病例(97.8%)发生在白人人群中。性别间发病率存在显著差异(男性,4.9[4.6 - 5.2]95%CI区间;女性,3.7[3.5 - 3.9]95%CI区间)。登记处地理位置及整个观察期内发病率无显著差异(卡方检验)。
美国葡萄膜黑色素瘤的平均年龄调整发病率(每百万4.3例)与欧洲国家报告的相似。过去25年中,葡萄膜黑色素瘤的年龄调整发病率保持稳定。